Enhance your patent search with AI. Try the FREE AI-powered tool

Google’s US9848780 and Amazon’s US9750420: Subtle Moves Towards Tech’s Big Healthcare Push

cover photo for google and amazon's technical patent anaylsis

Google’s US9848780 and Amazon’s US9750420: Subtle Moves Towards Tech’s Big Healthcare Push

Tech’s onward healthcare march

We present in this article a comparison between two patents issued to Google and Amazon Technologies, Inc. that relate to non-contact systems and methods for physiological parameter (e.g., heart rate) measurement. The two patents were granted relatively recently, with both their effective filing and grant dates being only within about four months from each other. The question is: do we really need another technique to measure pulse rates? And why would two very big, very ambitious, and very powerful companies bother to develop a healthcare-related invention directed to a now common patent subject matter? Obviously, there is more to this than meets the eye. We are talking about Google and Amazon, after all. For one, Amazon has just recently announced its alliance with Berkshire Hathaway and JP Morgan to establish a healthcare company with an ambition befitting its founders’ size and reputation. Google, on the other hand, has already invested in more than 50 healthcare companies. In fact, healthcare has been for some time now a major, although relatively low-profile, investment area for many of the biggest names in the tech industry including Microsoft, Apple, Samsung, and Intel. Part of the reason is improvements within the healthcare industry offer revenue growth opportunities projected to be worth more than $500 billion. Also, companies like Google, Amazon, Apple, Microsoft and IBM possess massive resources—especially hardware and software expertise in the field of AI, natural language processing, vision, pattern recognition, search, health monitoring systems, including mobile and cloud computing—required to develop tools that might just revolutionize healthcare services delivery. Further, the amount of clinical, biomedical, and genomic data being generated every year continues to increase exponentially. Making sense of these tremendous amount of data and extracting insights for use in, for example, clinical decision support would only be feasible through the implementation of sophisticated data analytics technologies across the entire industry. Of course, each of these giant tech companies also has a massive stash of cash to fund their foray into a colossus of an industry. In addition, the healthcare industry’s enormous size provides ample room for each of them to position their newly-developed products and services.

Know the landscape. Get ahead.

Get customized, comprehensive patent landscape reports on your chosen technology area.

Subscribe to our newsletter

  • Questions? Check our privacy policy.
  • This field is for validation purposes and should be left unchanged.

Sign up to get access

"*" indicates required fields

Name*
By signing, you accept Parola Analytics terms of service and privacy policy, and agree to receive occasional email about campaigns. you can unsubscribe anytime.
Hidden
Hidden
This field is for validation purposes and should be left unchanged.

Patent and IP updates straight to your inbox

Sign up now to receive monthly patent news, analysis and free insight reports.

We don’t spam, we promise.

Disclaimer: 

1. Parola Analytics and Avontis are distinct entities and operate independently. Any references to Avontis or its services do not constitute a legal partnership. 

2. Parola Analytics does not provide legal services. Our services are limited to research and technical analysis. Any information provided by Parola Analytics should not be construed as legal advice.